VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a Technology Evaluation and License Option Agreement (“TELOA”) with Wyckoff Farms Inc. (“Wyckoff Farms”) to trial the use of a 10kW Radiant Energy Vacuum (“REV™”) dehydration machine for the drying of premium hop products. The 10kW REV™ machinery will be installed at Wyckoff Farms’ facility located in Grandview, Washington, USA. During the term of the TELOA, Wyckoff Farms will hold an exclusive option to license EnWave’s technology for the drying of hop products in the United States of America.
Wyckoff Farms is the parent company of MicroDried®, one of EnWave’s longest standing licensed partners of REV™ drying technology. Since 2012, MicroDried® has used REV™ drying to create 100% all-natural, high quality dried fruit and vegetables that are rich in nutritional values and health benefits. Over the past decade, Wyckoff Farms has solidified its commitment to REV™ technology by scaling up to three large-scale REV™ machines, all operating at MicroDried’s processing facility in Nampa, Idaho.
MicroDried® operates a full-scale production facility in Nampa, ID for the production of all MicroDried fruit and vegetable ingredients. The company is committed to the highest domestic and international certification standards in the industry. Plant certifications include British Retail Consortium (BRC), AIB International and Orthodox Union (OU) Kosher. All fruit and vegetable products offer a clean single-ingredient label, are naturally low in fat, sodium and cholesterol, are non-GMO, gluten and allergen free, and are made in the USA.
For more information, please visit microdried.com.
EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Vancouver, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV™) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity and product quality.
With more than fifty royalty-generating partners spanning twenty countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.
EnWave’s strategy is to sign royalty-bearing commercial licenses with food and cannabis producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits:
Food and ingredients companies can produce exciting new products, reach optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.
Cannabis producers can dry four to six times faster, retain 20% more terpenes and 25% more cannabinoids, and achieve at least a 3-log reduction in crop-destroying microbes.
Learn more at EnWave.net.
Mr. Brent Charleton, CFA
President and CEO
For further information:
Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
Dan Henriques, CFO at +1 (604) 835-5212
Media inquiries: firstname.lastname@example.org
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.